Gerresheimer AG (ETR:GXI) has received an average recommendation of “Hold” from the eleven research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is €72.64 ($86.48).

A number of equities research analysts have weighed in on the stock. Kepler Capital Markets set a €65.00 ($77.38) target price on shares of Gerresheimer and gave the company a “sell” rating in a research note on Friday, November 3rd. Deutsche Bank set a €64.00 ($76.19) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Friday. Goldman Sachs Group set a €69.50 ($82.74) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Thursday, October 12th. Independent Research set a €68.00 ($80.95) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Wednesday, October 11th. Finally, J P Morgan Chase & Co set a €99.40 ($118.33) target price on shares of Gerresheimer and gave the company a “buy” rating in a research note on Wednesday, October 11th.

Shares of Gerresheimer (ETR:GXI) opened at €67.18 ($79.98) on Monday. Gerresheimer has a 12 month low of €59.97 ($71.39) and a 12 month high of €78.25 ($93.15).

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/12/04/gerresheimer-ag-gxi-given-average-rating-of-hold-by-analysts.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.